Neogenomics Inc. announced earnings results for the first quarter ended March 31, 2008. For the quarter, the company reported a net loss of $265,363 or $0.01 per share on the revenue of $4,162,762 against the net loss of $219,545 or $0.01 per share on the revenue of $2,242,661 for the same period a year ago.

Neogenomics Inc., Q1 2008 Earnings/Operating Results Call, May-07-2008

Neogenomics Inc. restated earnings results for the year ended December 31, 2007. The audited financial statements for the year ended December 31, 2007 included in the 10-KSB included an additional contingency charge expense of approximately $177,000 versus the unaudited results issued on March 18, 2008. This contingency charge was for registration penalties have been incurring as a result of delays in completing an effective registration statement for the shares of the company sold in June 2007 private placement. In accordance with FASB Staff Position 00-19-2, Accounting for Registration Payment Arrangements, the company accrued approximately $177,000 of penalty expense as of December 31, 2007 for the liquidated damages expected through May 2008. As a result of this change, the audited net loss for year 2007 has increased by $177,000 versus the net loss issued in its March 18, 2008 earnings release.